ImmunityBio, Inc. — Director's Dealing 2016

Sep 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NantKwest, Inc. (NK)
CIK: 0001326110
Period of Report: 2016-09-07

Reporting Person: Simon Barry J. (Director, President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-07	Common Stock	S	2000	$8.8356	Disposed	21143	Indirect
2016-09-08	Common Stock	S	30000	$7.40	Disposed	3334906	Direct

Footnotes

F1: Represents the weighted average share price of an aggregate total of 400 shares sold in the price range of $60.00 to $60.01 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.